Colorectal Cancer Clinical Trials in San Antonio, TX

Colorectal Cancer Clinical Trials in San Antonio, TX

View the best 10 colorectal cancer medical studies in San Antonio, Texas. Access promising new therapies by applying to a San Antonio-based Colorectal Cancer clinical trial.

Top rated colorectal cancer clinical trials in San Antonio, Texas

Here are the top 10 medical studies for colorectal cancer in San Antonio, Texas

Image of The Oncology Institute of Hope and Innovation in Glendale, United States.

RO7198457

Cancer Vaccine

Recruiting1 awardPhase 2
This trial compares the efficacy of RO7198457 to watchful waiting in patients with ctDNA positive, resected Stage II/III rectal cancer, or Stage II (high risk)/Stage III colon cancer.
Image of HonorHealth Research Institute in Scottsdale, United States.

INBRX-109

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial is testing a new drug, INBRX-109, which is a recombinant humanized tetravalent antibody targeting the human death receptor 5 (DR5). This is the first time this drug is being tested in humans. The trial has three parts.
Image of Carta - Clinical Associates in Research Therapeutics of America, LLC in San Antonio, United States.

Ponsegromab +1 More

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial will test if a new drug is effective, safe, and tolerable for treating cancer-related cachexia and elevated GDF 15 levels.
Image of Sarah Cannon Research Institute (SCRI) at HealthONE in Denver, United States.

IGM-8444 +6 More

Monoclonal Antibodies

Verified
Recruiting1 awardPhase 1
This trial will test if aplitibart in combination with FOLFIRI chemotherapy and bevacizumab is safe and effective in treating colorectal cancer that has relapsed or spread.
Image of Yuma Regional Medical Center in Yuma, United States.

Niraparib

PARP Inhibitor

Recruiting1 awardPhase 2
This trial will help researchers learn more about how effective niraparib is for treating solid tumors with a PALB2 mutation.
Image of Los Angeles County-USC Medical Center in Los Angeles, United States.

Ceralasertib +1 More

Enzyme Inhibitor

Recruiting1 awardPhase 1
This trial will find the best dose and safety of ceralasertib when given with trastuzumab deruxtecan to treat patients with solid tumors that have a change in the HER2 gene or protein.
Image of Weill Cornell Medical College in New York, United States.

KPT-8602

XPO1 inhibitor

Recruiting1 awardPhase 1 & 2
This trial will assess the safety, tolerability, and preliminary efficacy of KPT-8602, an oral XPO1 inhibitor, in patients with relapsed/refractory multiple myeloma, metastatic colorectal cancer, metastatic castration resistant prostate cancer, higher risk myelodysplastic syndrome, acute myeloid leukemia, and newly diagnosed intermediate/high-risk MDS.
Image of START Midwest in Grand Rapids, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial is testing a new drug, NGM831, as a possible treatment for advanced or metastatic solid tumors.
Image of CTCA at Western Regional Medical Center in Goodyear, United States.

Trastuzumab +3 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial studies trastuzumab and pertuzumab compared to cetuximab and irinotecan hydrochloride in treating patients with HER2/neu amplified colorectal cancer.
Image of Alabama Oncology, Bruno Cancer Center in Birmingham, United States.

mFOLFOX6 Regimen +3 More

Small Molecule

Recruiting2 awardsPhase 3
This trial is testing a new drug, MRTX849, to see if it is better than chemotherapy at treating colorectal cancer that has a KRAS G12C mutation.

Popular filter options for colorectal-cancer san-antonio trials

Phase 3 Clinical Trials

View 58 phase 3 medical studies.

Clinical Trials With No Placebo

View 58 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.